Clinical trial
Study of Paxil Use in Menopausal Women
NCT00225914 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00225914 |
|---|---|
| Title | Study of Paxil Use in Menopausal Women |
| Official title | Paroxetine Controlled Release in the Treatment of Symptomatic Menopausal Women Following Discontinuation of Hormone Therapy |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | Paroxetine, placebo |
| Enrollment | 64 |
| Start date | Sep 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 26, 2005 |
| Last update posted | Nov 24, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: